Germaine Wong
Germaine Wong is an expert in Surgery at Westmead Hospital (Australia). As of October 2026, ScienceLeadR ranks Germaine Wong in the top 1% of experts worldwide for Kidney Transplantation and Epidemiologic Studies. Germaine Wong has authored 599 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 5 of them ongoing. SLR score: 2,195 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Transplantation - Nephrology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 599
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Uprooting inequity: cultivating a flourishing and socially accountable nephrologist workforce for Indigenous peoples. PMID 42745065 — kidney diseases, nephrologists, socioeconomic factors, workforce | Nat Rev Nephrol Top journal | 2026 | 0 |
| Potential Neonatal Donors in Australia: A National Cohort Study. PMID 42686207 — infant, newborn, cohort studies, infant | Pediatrics | 2026 | 0 |
| Kidney Allograft Outcomes in Borderline and T Cell-Mediated Rejection With Microvascular Inflammation. PMID 42666913 — registries, cells, factor ix, absenteeism, phenotype, kidney, graft survival, transplants, t-lymphocytes, allografts | Kidney Int Rep | 2026 | 0 |
| "How I Do it": Caring for Solid Organ Transplant Recipients and Candidates who Need Immune Checkpoint Inhibitors. PMID 42576173 — immune checkpoint inhibitors, transplants, transplantation | Transplantation | 2026 | 0 |
| IgAN in South Asia. PMID 42569365 | Kidney Int Rep | 2026 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney Pancreas Transplant Recipients NCT06474273 — graft rejection, cells, psychology, methylprednisolone, prednisone, kidney, rejection, psychology, pancreas, transplants, steroids, t-lymphocytes | Phase 3 | Recruiting | 2026 |
| Bringing Optimised COVID 19 Vaccine Schedules To ImmunoCompromised Populations (BOOST IC) an Adaptive Randomised Controlled Clinical Trial NCT05556720 — cells, sars-cov-2, safety, vaccines, covid-19 vaccines, lymphoma, leukemia, lymphocytic, chronic, b-cell, leukemia, rna, messenger, leukemia, lymphoid, multiple myeloma, hiv, covid-19, lymphoma, non-hodgkin, organ transplantation, b-lymphocytes, transplantation | Phase 3 | Active not recruiting | 2022 |
| The RENAL LIFECYCLE Trial A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD NCT05374291 — diabetes mellitus, kidney diseases, sodium-glucose transporter 2 inhibitors, mortality, chronic disease, hospitalization, heart failure, heart, kidney, echocardiography, transplants, therapeutics, renal insufficiency, renal insufficiency, chronic | Phase 3 | Active not recruiting | 2022 |
| Prevalence of BK Viremia in Simultaneous Liver Kidney Transplant NCT05224583 — liver transplantation, polyomavirus infections, polyomavirus, kidney, liver, viremia, prevalence, transplants, infections | N/A | Enrolling by invitation | 2021 |
| A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients NCT05325008 — kidney diseases, psychology, polyomavirus infections, polyomavirus, kidney, immunoglobulins, rejection, psychology, pancreas, nephrology, viremia, viruses, transplants, kidney transplantation, immunosuppression therapy, allografts, transplantation, infections, immunoglobulins, intravenous, virus diseases | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map